Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 2/2009

01-10-2009 | Poster presentation

Breast screening unit size and performance on self-assessment (PERFORMS)

Published in: Breast Cancer Research | Special Issue 2/2009

Login to get access

Excerpt

The UK Breast Screening Programme (UKBSP) is comprised of approximately 100 individual Breast Screening Units (BSUs) that vary in size (measured by number of women screened). Previous research using UKBSP real life data (Blanks, Bennett, Wallis and Moss, 2002), attributed differences in performance, related to BSU size, to smaller units' slightly lowered cancer detection rates and positive predictive value scores (compared to large/medium units). …
Metadata
Title
Breast screening unit size and performance on self-assessment (PERFORMS)
Publication date
01-10-2009
Published in
Breast Cancer Research / Issue Special Issue 2/2009
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr2383

Other articles of this Special Issue 2/2009

Breast Cancer Research 2/2009 Go to the issue

Poster presentation

In the NHS breast screening programme does radiographer-reported clinical history add value to mammography?

Oral presentation

Surgical management of women with screen-detected breast cancer: preoperative factors indicating risk of multiple operations versus a single operation in women undergoing surgery for screen detected breast cancer

Poster presentation

Negative axillary ultrasound in primary breast cancer: how reassured should we really be?

Oral presentation

Pathological features and patterns of metastatic disease in locally advanced inflammatory and non-inflammatory breast cancer

Poster presentation

Does breast magnetic resonance imaging measurement correlate with pathology in assessment of primary breast cancer?

Poster presentation

Does magnetic resonance imaging alter the clinical management of patients with breast cancer? A three year single centre experience
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits